A clinical-stage biotechnology company focused on developing therapeutic candidates for immune-mediated and inflammatory diseases. Its valuation is largely tied to the progress of its research pipeline, clinical trial results, and regulatory milestones. Investors monitor the company for updates on d...
No congressional trades have been disclosed for Auro Biotech Incorporated (AURO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.